Melissa Martyn

1.8k total citations
40 papers, 647 citations indexed

About

Melissa Martyn is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Melissa Martyn has authored 40 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Economics and Econometrics. Recurrent topics in Melissa Martyn's work include Genomics and Rare Diseases (20 papers), BRCA gene mutations in cancer (12 papers) and Ethics in Clinical Research (9 papers). Melissa Martyn is often cited by papers focused on Genomics and Rare Diseases (20 papers), BRCA gene mutations in cancer (12 papers) and Ethics in Clinical Research (9 papers). Melissa Martyn collaborates with scholars based in Australia, United Kingdom and United States. Melissa Martyn's co-authors include Clara Gaff, Zornitza Stark, Sebastian Lunke, Susan M. White, Tiong Yang Tan, Ilias Goranitis, Deborah Schofield, Rupendra Shrestha, Khurshid Alam and Elly Lynch and has published in prestigious journals such as Journal of Clinical Oncology, Quality of Life Research and The Laryngoscope.

In The Last Decade

Melissa Martyn

37 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melissa Martyn Australia	14	415	111	100	89	63	40	647
Sawona Biswas United States	10	374 0.9×	110 1.0×	61 0.6×	88 1.0×	10 0.2×	13	513
Colin Halverson United States	14	373 0.9×	46 0.4×	333 3.3×	84 0.9×	59 0.9×	39	666
Seema M. Jamal United States	12	487 1.2×	259 2.3×	170 1.7×	81 0.9×	32 0.5×	16	790
Tyler W. Buckner United States	19	43 0.1×	88 0.8×	41 0.4×	69 0.8×	26 0.4×	52	873
L. F. Ross United States	3	208 0.5×	54 0.5×	70 0.7×	122 1.4×	11 0.2×	4	336
Emily Kim United States	13	220 0.5×	264 2.4×	28 0.3×	25 0.3×	13 0.2×	51	587
Karen E. Wain United States	14	378 0.9×	120 1.1×	53 0.5×	123 1.4×	12 0.2×	28	567
Elisa R. Berson United States	11	44 0.1×	44 0.4×	56 0.6×	206 2.3×	12 0.2×	19	492
Joeri Meijsen Denmark	6	374 0.9×	130 1.2×	43 0.4×	48 0.5×	7 0.1×	9	584
Sarah Norris Australia	13	88 0.2×	60 0.5×	84 0.8×	30 0.3×	84 1.3×	44	491

Countries citing papers authored by Melissa Martyn

Since Specialization

Citations

This map shows the geographic impact of Melissa Martyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Martyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Martyn more than expected).

Fields of papers citing papers by Melissa Martyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Martyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Martyn. The network helps show where Melissa Martyn may publish in the future.

Co-authorship network of co-authors of Melissa Martyn

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Martyn. A scholar is included among the top collaborators of Melissa Martyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Martyn. Melissa Martyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schilling, Chris, et al.. (2025). Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023. European Journal of Human Genetics. 33(8). 1044–1050. 3 indexed citations

Martyn, Melissa, et al.. (2025). Building capability for clinician-led genomic change: insights from use and non-use of a theory-informed model for change. Frontiers in Genetics. 16. 1692703–1692703.

McClaren, Belinda, et al.. (2025). Opportunities and challenges for paediatricians requesting funded genomic tests for children. European Journal of Human Genetics. 33(9). 1173–1179. 2 indexed citations

Martyn, Melissa, et al.. (2024). Secondary use of genomic data: patients’ decisions at point of testing and perspectives to inform international data sharing. European Journal of Human Genetics. 32(6). 717–724. 4 indexed citations

Patel, Chirag, John Christodoulou, Belinda McClaren, et al.. (2024). A national education program for rapid genomics in pediatric acute care: Building workforce confidence, competence, and capability. Genetics in Medicine. 26(10). 101224–101224. 3 indexed citations

Lee, Ling, Fiona Lynch, Melissa Martyn, et al.. (2023). Two-step offer and return of multiple types of additional genomic findings to families after ultrarapid trio genomic testing in the acute care setting: a study protocol. BMJ Open. 13(6). e072999–e072999. 7 indexed citations

Martyn, Melissa, et al.. (2023). What matters to parents? A scoping review of parents’ service experiences and needs regarding genetic testing for rare diseases. European Journal of Human Genetics. 31(8). 869–878. 6 indexed citations

Jayasinghe, Kushani, You Wu, Zornitza Stark, et al.. (2021). Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases. Kidney International Reports. 6(11). 2850–2861. 27 indexed citations

Downie, Lilian, David J. Amor, Jane Halliday, et al.. (2020). Exome Sequencing for Isolated Congenital Hearing Loss: A Cost‐Effectiveness Analysis. The Laryngoscope. 131(7). E2371–E2377. 10 indexed citations

10.

Downie, Lilian, Jane Halliday, Sharon Lewis, et al.. (2020). Exome sequencing in newborns with congenital deafness as a model for genomic newborn screening: the Baby Beyond Hearing project. Genetics in Medicine. 22(5). 937–944. 32 indexed citations

11.

Blombery, Piers, Lucy C. Fox, Georgina L. Ryland, et al.. (2020). Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure syndromes. Haematologica. 106(1). 64–73. 11 indexed citations

12.

Martyn, Melissa, et al.. (2020). “It’s something I’ve committed to longer term”: The impact of an immersion program for physicians on adoption of genomic medicine. Patient Education and Counseling. 104(3). 480–488. 8 indexed citations

13.

Stark, Zornitza, Amy Nisselle, Belinda McClaren, et al.. (2019). Attitudes of Australian health professionals towards rapid genomic testing in neonatal and paediatric intensive care. European Journal of Human Genetics. 27(10). 1493–1501. 37 indexed citations

14.

Tan, Tiong Yang, Sebastian Lunke, Belinda Chong, et al.. (2019). A head-to-head evaluation of the diagnostic efficacy and costs of trio versus singleton exome sequencing analysis. European Journal of Human Genetics. 27(12). 1791–1799. 35 indexed citations

15.

Best, Stephanie, Janet C. Long, Melissa Martyn, et al.. (2019). Amalgamating theoretical frameworks to understand individual and organisational level implementation. Implementation Science. 14. 1 indexed citations

16.

Jayasinghe, Kushani, Zornitza Stark, Chirag Patel, et al.. (2019). Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol. BMJ Open. 9(8). e029541–e029541. 12 indexed citations

17.

Taylor, Natalie, Stephanie Best, Melissa Martyn, et al.. (2019). A transformative translational change programme to introduce genomics into healthcare: a complexity and implementation science study protocol. BMJ Open. 9(3). e024681–e024681. 24 indexed citations

18.

Ramchand, Jay, Melissa Martyn, David L. Hare, et al.. (2019). A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathy. Genetics in Medicine. 21(12). 2815–2822. 30 indexed citations

19.

Cotter, Megan, Alison D. Archibald, Belinda McClaren, et al.. (2016). Clinical audit of genetic testing and referral patterns for fragile X and associated conditions. American Journal of Medical Genetics Part A. 170(6). 1439–1449. 7 indexed citations

20.

Martyn, Melissa, Vicki Anderson, Alison D. Archibald, et al.. (2013). Offering fragile X syndrome carrier screening: a prospective mixed-methods observational study comparing carrier screening of pregnant and non-pregnant women in the general population. BMJ Open. 3(9). e003660–e003660. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact